<DOC>
	<DOCNO>NCT00780351</DOCNO>
	<brief_summary>1 . Sustained low efficiency daily hemodiafiltration ( SLEDD-f ) kind renal replacement therapy high-flux dialyser membrane ( helixone ) . 2 . The pore size helixone large antibiotic , vancomycin suppose removed dialysis . 3 . Our study want find amount vancomycin remove SLEDD-f , try find appropriate dose regimen kind patient .</brief_summary>
	<brief_title>Dosing Vancomycin Patients Sustained Low Efficiency Daily Hemodiafiltration ( SLEDD-f )</brief_title>
	<detailed_description>Vancomycin important antibiotic treatment resistant G ( + ) bacteria infection . Close monitor serum level important ensure safety effectiveness . So far enough data support optimal dose regimen vancomycin patient SLEDD-f . In study , draw blood level 2 dos vancomycin determine pharmacokinetic parameter vancomycin fraction remove SLEDD-f determine appropriate dose regimen .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Acute renal failure cause Use SLEDDf renal replacement therapy Priscribe vancomycin know suspected infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>vancomycin , SLEDD-f</keyword>
</DOC>